175 related articles for article (PubMed ID: 7929724)
1. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors.
Lyons CA; Wheeler CA; Frishman GN; Hackett RJ; Seifer DB; Haning RV
Hum Reprod; 1994 May; 9(5):792-9. PubMed ID: 7929724
[TBL] [Abstract][Full Text] [Related]
2. In-vitro fertilization and the ovarian hyperstimulation syndrome.
MacDougall MJ; Tan SL; Jacobs HS
Hum Reprod; 1992 May; 7(5):597-600. PubMed ID: 1639974
[TBL] [Abstract][Full Text] [Related]
3. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients.
Al-Shawaf T; Zosmer A; Hussain S; Tozer A; Panay N; Wilson C; Lower AM; Grudzinskas JG
Hum Reprod; 2001 Jan; 16(1):24-30. PubMed ID: 11139531
[TBL] [Abstract][Full Text] [Related]
4. An aggressive philosophy in controlled ovarian stimulation cycles increases pregnancy rates.
Gratton RJ; Nisker JA; Daniel S; Toth S; Gunter J; Kaplan BR; Tummon IS; Yuzpe AA
Hum Reprod; 1993 Apr; 8(4):528-31. PubMed ID: 8501179
[TBL] [Abstract][Full Text] [Related]
5. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?
Lee C; Tummon I; Martin J; Nisker J; Power S; Tekpetey F
Hum Reprod; 1998 May; 13(5):1157-8. PubMed ID: 9647538
[TBL] [Abstract][Full Text] [Related]
6. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
Lainas GT; Lainas TG; Sfontouris IA; Chatzimeletiou K; Venetis CA; Bosdou JK; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
Hum Reprod; 2019 Sep; 34(9):1770-1777. PubMed ID: 31384921
[TBL] [Abstract][Full Text] [Related]
7. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
[TBL] [Abstract][Full Text] [Related]
8. 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization.
Sher G; Zouves C; Feinman M; Maassarani G
Hum Reprod; 1995 Dec; 10(12):3107-9. PubMed ID: 8822423
[TBL] [Abstract][Full Text] [Related]
9. Luteal phase support and severe ovarian hyperstimulation syndrome.
McClure N; Leya J; Radwanska E; Rawlins R; Haning RV
Hum Reprod; 1992 Jul; 7(6):758-64. PubMed ID: 1500471
[TBL] [Abstract][Full Text] [Related]
10. Relationship between human chorionic gonadotropin serum levels and the risk of ovarian hyperstimulation syndrome.
Johnson MD; Williams SL; Seager CK; Liu JH; Barker NM; Hurd WW
Gynecol Endocrinol; 2014 Apr; 30(4):294-7. PubMed ID: 24455971
[TBL] [Abstract][Full Text] [Related]
11. [GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome].
Guivarc'h-Levêque A; Jaffré F; Homer L; Moy L; Priou G; Colleu D; Denis I; Arvis P
Gynecol Obstet Fertil; 2013 Sep; 41(9):511-4. PubMed ID: 23972925
[TBL] [Abstract][Full Text] [Related]
12. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
[TBL] [Abstract][Full Text] [Related]
13. Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial.
Elgindy EA; Sibai H; Mostafa MI; Gibreel A; Darwish E; Maghraby H
Hum Reprod; 2018 Jun; 33(6):1079-1086. PubMed ID: 29562260
[TBL] [Abstract][Full Text] [Related]
14. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
[TBL] [Abstract][Full Text] [Related]
15. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
[TBL] [Abstract][Full Text] [Related]
16. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
[TBL] [Abstract][Full Text] [Related]
18. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
Lewit N; Kol S; Manor D; Itskovitz-Eldor J
Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
[TBL] [Abstract][Full Text] [Related]
20. Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression--a prospective randomized study.
Schwärzler P; Abendstein BJ; Klingler A; Kreuzer E; Rjosk HK
Hum Fertil (Camb); 2003 Aug; 6(3):125-9. PubMed ID: 12960445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]